Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Inhibikase Therapeutics I...

    NASDAQ: IKT · Real-Time Price · USD
    1.89
    0.21 (12.50%)
    At close: Aug 22, 2025, 3:59 PM
    1.89
    0.00%
    After-hours: Aug 22, 2025, 04:10 PM EDT

    Inhibikase Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -27.52M -19.03M -18.05M -14.79M
    Depreciation & Amortization
    		 26.27K 177.4K 6.72K n/a
    Stock-Based Compensation
    		 8.14M 500.15K 458.15K 1.53M
    Other Working Capital
    		 -66.85K 699.28K 39.53K -2.33M
    Other Non-Cash Items
    		 n/a 31.54K 67K 721.63K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 204.93K 234.76K 171.18K -1.76M
    Operating Cash Flow
    		 -19.15M -18.09M -17.35M -14.3M
    Capital Expenditures
    		 n/a -14.24K -243.25K n/a
    Cash Acquisitions
    		 n/a n/a 243.25K n/a
    Purchase of Investments
    		 -60.46M -29.43M -20.73M n/a
    Sales Maturities Of Investments
    		 23.45M 41.1M 4.96M n/a
    Other Investing Acitivies
    		 n/a n/a -243.25K n/a
    Investing Cash Flow
    		 -37M 11.66M -16.01M n/a
    Debt Repayment
    		 n/a n/a -248.91K -42.53K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a 848.00
    Financial Cash Flow
    		 103.48M 8.41M -204.77K 41.09M
    Net Cash Flow
    		 47.33M 1.98M -33.56M 26.8M
    Free Cash Flow
    		 -19.15M -18.1M -17.59M -14.3M

    Add to Watchlist